tiprankstipranks
Nuvectis Pharma (NVCT)
NASDAQ:NVCT
US Market

Nuvectis Pharma (NVCT) Income Statement

Compare
89 Followers

Nuvectis Pharma Income Statement

Last quarter (Q3 2024), Nuvectis Pharma's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Nuvectis Pharma's net income was $-4.15M. See Nuvectis Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 149.00K$ 0.00$ 0.00
Gross Profit
$ -22.90M$ -19.09M$ -12.89M$ 0.00
Operating Expenses
$ 22.90M$ 19.23M$ 12.89M$ 10.00K
Depreciation and Amortization
$ -1.00M$ -1.20M$ -7.10M$ 24.00K
EBITDA
$ -22.90M$ -19.23M$ -12.89M$ 0.00
Operating Income
$ -22.90M$ -19.23M$ -12.89M$ -10.00K
Other Income/Expenses
$ 637.00K$ 149.00K$ 4.00K$ 14.00K
Pretax Income
$ -22.26M$ -19.09M$ -12.89M$ -10.00K
Net Income
$ -22.26M$ -18.79M$ -12.89M$ -10.00K
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.43$ -1.48$ -1.01$ 0.00
Diluted EPS
$ -1.43$ -1.48$ -1.01$ 0.00
Weighted Average Shares Outstanding
15.56M 12.66M 12.72M 12.72M
Weighted Average Shares Outstanding (Diluted)
15.56M 12.66M 12.72M 12.72M
Currency in USD

Nuvectis Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis